Search Results - "Wehkamp, J."

Refine Results
  1. 1

    Innate immune dysfunction in inflammatory bowel disease by Gersemann, M., Wehkamp, J., Stange, E. F.

    Published in Journal of internal medicine (01-05-2012)
    “…  Gersemann M, Wehkamp J, Stange EF (Robert Bosch Hospital, Stuttgart; Dr. Margarete Fischer‐Bosch Institute of Clinical Pharmacology, Stuttgart and…”
    Get full text
    Journal Article
  2. 2

    Paneth cell α-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments by Ehmann, D., Wendler, J., Koeninger, L., Larsen, I. S., Klag, T., Berger, J., Marette, A., Schaller, M., Stange, E. F., Malek, N. P., Jensen, B. A. H., Wehkamp, J.

    “…Antimicrobial peptides, in particular α-defensins expressed by Paneth cells, control microbiota composition and play a key role in intestinal barrier function…”
    Get full text
    Journal Article
  3. 3

    Probiotic lactobacilli and VSL#3 induce enterocyte β-defensin 2 by Schlee, M, Harder, J, Köten, B, Stange, E.F, Wehkamp, J, Fellermann, K

    Published in Clinical and experimental immunology (01-03-2008)
    “…Recent evidence suggests that probiotic bacteria may stabilize gut barrier function via induction of anti-microbial peptides such as defensins. This study…”
    Get full text
    Journal Article
  4. 4

    Paneth cell α-defensin 6 (HD-6) is an antimicrobial peptide by Schroeder, B O, Ehmann, D, Precht, J C, Castillo, P A, Küchler, R, Berger, J, Schaller, M, Stange, E F, Wehkamp, J

    Published in Mucosal immunology (01-05-2015)
    “…Defensins protect human barriers from commensal and pathogenic microorganisms. Human α-defensin 6 (HD-6) is produced exclusively by small intestinal Paneth…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Bacterial Periplasmic Oxidoreductases Control the Activity of Oxidized Human Antimicrobial β-Defensin 1 by Wendler, J, Ehmann, D, Courth, L, Schroeder, B O, Malek, N P, Wehkamp, J

    Published in Infection and immunity (01-04-2018)
    “…The antimicrobial peptide human β-defensin 1 (hBD1) is continuously produced by epithelial cells in many tissues. Compared to other defensins, hBD1 has only…”
    Get full text
    Journal Article
  7. 7

    Barrier dysfunction due to distinct defensin deficiencies in small intestinal and colonic Crohn's disease by Wehkamp, J, Koslowski, M, Wang, G, Stange, E F

    Published in Mucosal immunology (01-11-2008)
    “…Defensins are endogenous antibiotics with broad microbicidal activity. A disturbed antimicrobial defense, as provided by Paneth and other epithelial defensins,…”
    Get full text
    Journal Article
  8. 8

    NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression by Wehkamp, J, Harder, J, Weichenthal, M, Schwab, M, Schäffeler, E, Schlee, M, Herrlinger, K R, Stallmach, A, Noack, F, Fritz, P, Schröder, J M, Bevins, C L, Fellermann, K, Stange, E F

    Published in Gut (01-11-2004)
    “…Background: Mutations in NOD2, a putative intracellular receptor for bacterial peptidoglycans, are associated with a subset of Crohn’s disease but the…”
    Get full text
    Journal Article
  9. 9

    Probiotic E. coli treatment mediates antimicrobial human β-defensin synthesis and fecal excretion in humans by Möndel, M, Schroeder, B O, Zimmermann, K, Huber, H, Nuding, S, Beisner, J, Fellermann, K, Stange, E F, Wehkamp, J

    Published in Mucosal immunology (01-03-2009)
    “…Inducible epithelial human β-defensins (hBD) play an important role in intestinal barrier function. In vitro studies showed that clinically effective…”
    Get full text
    Journal Article
  10. 10

    Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus by HERRLINGER, K. R., BARTHEL, D. N., SCHMIDT, K. J., BÜNING, J., BARTHEL, C. S., WEHKAMP, J., STANGE, E. F., FELLERMANN, K.

    Published in Alimentary pharmacology & therapeutics (01-05-2010)
    “…Aliment Pharmacol Ther 31, 1036–1041 Summary Background  The calcineurin inhibitor tacrolimus and the anti‐TNF‐antibody infliximab are established options in…”
    Get full text
    Journal Article
  11. 11

    Cell-mediated reduction of human β-defensin 1: a major role for mucosal thioredoxin by Jaeger, S U, Schroeder, B O, Meyer-Hoffert, U, Courth, L, Fehr, S N, Gersemann, M, Stange, E F, Wehkamp, J

    Published in Mucosal immunology (01-11-2013)
    “…Human β-defensin 1 (hBD-1) is an antimicrobial peptide expressed by epithelia and hematopoietic cells. We demonstrated recently that hBD-1 shows activity…”
    Get full text
    Journal Article
  12. 12

    A novel role for constitutively expressed epithelial-derived chemokines as antibacterial peptides in the intestinal mucosa by Kotarsky, K, Sitnik, K M, Stenstad, H, Kotarsky, H, Schmidtchen, A, Koslowski, M, Wehkamp, J, Agace, W W

    Published in Mucosal immunology (01-01-2010)
    “…Intestinal-derived chemokines have a central role in orchestrating immune cell influx into the normal and inflamed intestine. Here, we identify the chemokine…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Influence of standard treatment on ileal and colonic antimicrobial defensin expression in active Crohn’s disease by KÜBLER, I., KOSLOWSKI, M. J., GERSEMANN, M., FELLERMANN, K., BEISNER, J., BECKER, S., ROTHFUSS, K., HERRLINGER, K. R., STANGE, E. F., WEHKAMP, J.

    Published in Alimentary pharmacology & therapeutics (01-09-2009)
    “…Summary Background  Crohn’s Disease (CD), a chronic intestinal inflammation, is currently treated primarily by therapeutics which are directed against…”
    Get full text
    Journal Article
  15. 15

    Human beta-defensin 1: from defence to offence by Schroeder, B O, Stange, E F, Wehkamp, J

    Published in Zeitschrift fur Gastroenterologie (01-11-2012)
    “…The human gut is colonised by about one kilogram of commensal bacteria. These microorganisms are a potential threat, thus an efficient defence system is…”
    Get more information
    Journal Article
  16. 16

    Chronic Heavy Alcohol Use is Associated with Upregulated Paneth Cell Antimicrobials in Gastric Mucosa by Ostaff, M J, Schäfer, C, Courth, L, Stebe, S R D, Ott, G, Stange, E F, Wehkamp, J

    “…How alcohol consumption affects the integrity and the defense mechanisms of the mucosa in the upper gastrointestinal tract is largely unknown. We examined the…”
    Get full text
    Journal Article
  17. 17

    Innate immunity and colonic inflammation: Enhanced expression of epithelial α-defensins by WEHKAMP, J, SCHWIND, B, HERRLINGER, K. R, BAXMANN, S, SCHMIDT, K, DUCHROW, M, WOHLSCHLÄGER, C, FELLER, A. C, STANGE, E. F, FELLERMANN, K

    Published in Digestive diseases and sciences (01-06-2002)
    “…Human alpha-defensins contribute to local intestinal host defense as part of innate immunity and may be of major relevance in microbial infection and chronic…”
    Get full text
    Journal Article
  18. 18

    Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori status by Wehkamp, J, Schmidt, K, Herrlinger, K R, Baxmann, S, Behling, S, Wohlschläger, C, Feller, A C, Stange, E F, Fellermann, K

    Published in Journal of clinical pathology (01-05-2003)
    “…Background/Aims: Recent reports have suggested that Helicobacter pylori infection induces the mucosal antibiotic peptide human β defensin 2 (HBD-2). Therefore,…”
    Get full text
    Journal Article
  19. 19

    Defensin-immunology in inflammatory bowel disease by Wehkamp, J., Stange, E.F., Fellermann, K.

    Published in Gastroentérologie clinique et biologique (01-06-2009)
    “…Defensins are endogenous antibiotics with microbicidal activity against Gram-negative and Gram-positive bacteria, fungi, enveloped viruses and protozoa. A…”
    Get full text
    Journal Article
  20. 20